Year |
Citation |
Score |
2021 |
Fedele C, Li S, Teng KW, Foster CJR, Peng D, Ran H, Mita P, Geer MJ, Hattori T, Koide A, Wang Y, Tang KH, Leinwand J, Wang W, Diskin B, et al. SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling. The Journal of Experimental Medicine. 218. PMID 33045063 DOI: 10.1084/jem.20201414 |
0.345 |
|
2019 |
Zarei M, Du H, Nassar AH, Yan RE, Giannikou K, Johnson SH, Lam HC, Henske EP, Wang Y, Zhang T, Asara J, Kwiatkowski DJ. Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion. The Journal of Experimental Medicine. PMID 31506280 DOI: 10.1084/Jem.20190251 |
0.442 |
|
2019 |
Sun B, Mason S, Wilson RC, Hazard SE, Wang Y, Fang R, Wang Q, Yeh ES, Yang M, Roberts TM, Zhao JJ, Wang Q. Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. Oncogene. PMID 31462705 DOI: 10.1038/S41388-019-0953-9 |
0.418 |
|
2018 |
Wang Y, Li BB, Li J, Roberts TM, Zhao JJ. A Conditional Dependency on MELK for the Proliferation of Triple-Negative Breast Cancer Cells. Iscience. 9: 149-160. PMID 30391850 DOI: 10.1016/J.Isci.2018.10.015 |
0.427 |
|
2018 |
Wang Y, Li YM, Baitsch L, Huang A, Xiang Y, Tong H, Lako A, Von T, Choi C, Lim E, Min J, Li L, Stegmeier F, Schlegel R, Eck MJ, et al. Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife. 7. PMID 29528283 DOI: 10.7554/Elife.36414 |
0.385 |
|
2018 |
zarei M, Du H, Yan RE, Wang Y, Zhang T, Asara JM, Kwiatkowski DJ. Abstract LB-B24: Targeting transcriptional addiction for the treatment of TSC Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-Lb-B24 |
0.424 |
|
2017 |
Huang HT, Seo HS, Zhang T, Wang Y, Jiang B, Li Q, Buckley DL, Nabet B, Roberts JM, Paulk J, Dastjerdi S, Winter GE, McLauchlan H, Moran J, Bradner JE, et al. MELK is not necessary for the proliferation of basal-like breast cancer cells. Elife. 6. PMID 28926338 DOI: 10.7554/Elife.26693 |
0.365 |
|
2017 |
Huang H, Seo H, Zhang T, Wang Y, Jiang B, Li Q, Buckley DL, Nabet B, Roberts JM, Paulk J, Dastjerdi S, Winter GE, McLauchlan H, Moran J, Bradner JE, et al. Author response: MELK is not necessary for the proliferation of basal-like breast cancer cells Elife. DOI: 10.7554/Elife.26693.043 |
0.327 |
|
2016 |
Wang Y, Begley M, Li Q, Huang HT, Lako A, Eck MJ, Gray NS, Mitchison TJ, Cantley LC, Zhao JJ. Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival. Proceedings of the National Academy of Sciences of the United States of America. PMID 27528663 DOI: 10.1073/Pnas.1606862113 |
0.441 |
|
2015 |
Wang Y, Zhang T, Kwiatkowski N, Abraham BJ, Lee TI, Xie S, Yuzugullu H, Von T, Li H, Lin Z, Stover DG, Lim E, Wang ZC, Iglehart JD, Young RA, et al. CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer. Cell. 163: 174-186. PMID 26406377 DOI: 10.1016/J.Cell.2015.08.063 |
0.364 |
|
2014 |
Wu YY, V Nguyen A, Wu XX, Loh M, Vu M, Zou Y, Liu Q, Guo P, Wang Y, Montgomery LL, Orlofsky A, Rand JH, Lin EY. Antiphospholipid antibodies promote tissue factor-dependent angiogenic switch and tumor progression. The American Journal of Pathology. 184: 3359-75. PMID 25451155 DOI: 10.1016/J.Ajpath.2014.07.027 |
0.631 |
|
2014 |
Wang Y, Lee YM, Baitsch L, Huang A, Xiang Y, Tong H, Lako A, Von T, Choi C, Lim E, Min J, Li L, Stegmeier F, Schlegel R, Eck MJ, et al. MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife. 3: e01763. PMID 24844244 DOI: 10.7554/Elife.01763 |
0.375 |
|
2012 |
Fu K, Ren H, Wang Y, Fei E, Wang H, Wang G. DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD Oncogene. 31: 1311-1322. PMID 21785459 DOI: 10.1038/Onc.2011.315 |
0.329 |
|
2010 |
Wang Y, Karnataki A, Parsons M, Weiss LM, Orlofsky A. 3-Methyladenine blocks Toxoplasma gondii division prior to centrosome replication. Molecular and Biochemical Parasitology. 173: 142-53. PMID 20609430 DOI: 10.1016/J.Molbiopara.2010.05.020 |
0.689 |
|
2010 |
Wang Y, Weiss LM, Orlofsky A. Coordinate control of host centrosome position, organelle distribution, and migratory response by Toxoplasma gondii via host mTORC2. The Journal of Biological Chemistry. 285: 15611-8. PMID 20236941 DOI: 10.1074/Jbc.M109.095778 |
0.707 |
|
2010 |
Deng L, Zhou JF, Sellers RS, Li JF, Nguyen AV, Wang Y, Orlofsky A, Liu Q, Hume DA, Pollard JW, Augenlicht L, Lin EY. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. The American Journal of Pathology. 176: 952-67. PMID 20042677 DOI: 10.2353/Ajpath.2010.090622 |
0.66 |
|
2009 |
Wang Y, Weiss LM, Orlofsky A. Intracellular parasitism with Toxoplasma gondii stimulates mammalian-target-of-rapamycin-dependent host cell growth despite impaired signalling to S6K1 and 4E-BP1. Cellular Microbiology. 11: 983-1000. PMID 19302577 DOI: 10.1111/J.1462-5822.2009.01305.X |
0.701 |
|
2009 |
Wang Y, Weiss LM, Orlofsky A. Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. The Journal of Biological Chemistry. 284: 1694-701. PMID 19028680 DOI: 10.1074/Jbc.M807890200 |
0.698 |
|
2003 |
Wang YB, Lou Y, Luo ZF, Zhang DF, Wang YZ. Induction of apoptosis and cell cycle arrest by polyvinylpyrrolidone K-30 and protective effect of alpha-tocopherol. Biochemical and Biophysical Research Communications. 308: 878-84. PMID 12927801 DOI: 10.1016/S0006-291X(03)01485-2 |
0.309 |
|
Show low-probability matches. |